PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMedexus Pharmaceuticals
Medexus Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
RasuvoMethotrexate2014-07-102026-2033
Leukemia
,
Juvenile arthritis
,
Psoriatic arthritis
,
Breast neoplasms
,
Psoriasis
,
Stomach neoplasms
,
Esophageal neoplasms
,
Rheumatoid arthritis
,
Lung neoplasms
,
Crohn disease
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Hydatidiform mole
,
Osteosarcoma
,
Arthritis
,
Mycosis fungoides
,
Testicular neoplasms
,
Choriocarcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Trenonacog alfa
tay-sachs disease
,
sandhoff disease
,
gangliosidoses
,
gm2 gangliosidoses
,
hemophilia a
,
hemophilia b
,
ataxia
,
ataxia telangiectasia
,
telangiectasis
,
cerebellar ataxia
,
niemann-pick diseases
,
type a niemann-pick disease
,
frontotemporal dementia
,
type c niemann-pick disease
,
primary progressive aphasia
,
pick disease of the brain
Apvo101
hemophilia a
,
hemophilia b
Demand
von willebrand diseases
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
hemophilia a
,
hemophilia b
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use